LiveMint-Keywords


GSK withdraws Trizivir patent application ‘in public interest’ C.H. Unnikrishnan 12:58 AM \| October 10,2007 Trizivir is a fixed-dose combination tablet containing three drugs, lamivudine, zidovudine and abacavir sulfate FIND MORE ARTICLES ON: GSK patent GlaxoSmithKline Combivir